Cargando…

Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia

Detalles Bibliográficos
Autores principales:	Paulino, Eduardo, de Melo, Andreia Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543105/ https://www.ncbi.nlm.nih.gov/pubmed/31074249 http://dx.doi.org/10.3802/jgo.2019.30.e87

Ejemplares similares

Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia
por: Xue, Wei, et al.
Publicado: (2023)

Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide
por: Braga, Antonio, et al.
Publicado: (2019)

Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)

Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report
por: Mu, Xiyan, et al.
Publicado: (2018)

Comparison of the efficacy of methotrexate and actinomycin D in the treatment of patients with stage I low risk gestational trophoblastic neoplasia (GTN)
por: Shahbazian, Nahid, et al.
Publicado: (2014)

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia
por: Li, Lei, et al.
Publicado: (2018)

Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm
por: Peng, Mei, et al.
Publicado: (2015)

Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia
por: Braga, Antonio, et al.
Publicado: (2021)

Gestational trophoblastic neoplasia in the 1990s.
por: Goldstein, D. P.
Publicado: (1991)

Spontaneous regression of gestational trophoblastic neoplasia
por: Niimi, Kaoru, et al.
Publicado: (2017)

Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia
por: Blackwell, Conner, et al.
Publicado: (2023)

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275
por: Schink, Julian C., et al.
Publicado: (2020)

A review on management of gestational trophoblastic neoplasia
por: Sharami, Seyedeh Reyhaneh Yousefi, et al.
Publicado: (2020)

Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies
por: Hao, Jiatao, et al.
Publicado: (2021)

Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia
por: May, Taymaa, et al.
Publicado: (2011)

Role of surgical therapy in the management of gestational trophoblastic neoplasia
por: Eoh, Kyung Jin, et al.
Publicado: (2015)

Gestational trophoblastic neoplasia: experience at Salah Azaiez Institute
por: Batti, Rim, et al.
Publicado: (2019)

Conservative management of uterine rupture in gestational trophoblastic neoplasia
por: David-West, Gizelka, et al.
Publicado: (2020)

Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia
por: Singhal, Seema, et al.
Publicado: (2020)

Gestational trophoblastic neoplasia presenting as an interstitial ectopic pregnancy
por: Toal, C., et al.
Publicado: (2021)

Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN)
por: Mangili, Giorgia, et al.
Publicado: (2022)

Methotrexate pneumonitis in a patient with gestational trophoblastic neoplasia
por: Agarwal, M, et al.
Publicado: (2022)

Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease
por: Lee, Young-Jae, et al.
Publicado: (2017)

Challenges in treatment of gestational trophoblastic neoplasia in patients with MTHFR mutation: A case report
por: Patel, Jharna M., et al.
Publicado: (2023)

Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases
por: Braga, Antonio, et al.
Publicado: (2023)

Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, randomized trial
por: Jiang, Fang, et al.
Publicado: (2023)

Gestational trophoblastic neoplasia with retroperitoneal metastases: A fatal complication
por: Thomakos, Nikolaos, et al.
Publicado: (2010)

Gestational trophoblastic neoplasia: A 6 year retrospective study
por: Shrivastava, Sushruta, et al.
Publicado: (2014)

Human chorionic gonadotrophin as an indicator of persistent gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2014)

Radiographically occult pulmonary metastases from gestational trophoblastic neoplasia
por: Hong, Tina, et al.
Publicado: (2017)

Single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Mousavi Seresht, Leila, et al.
Publicado: (2023)

Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy
por: Cortés-Charry, R., et al.
Publicado: (2021)

A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
por: Powles, T, et al.
Publicado: (2007)

Gestational Trophoblastic Neoplasia Treatment at the Butaro Cancer Center of Excellence in Rwanda
por: Nzayisenga, Ignace, et al.
Publicado: (2016)

Pulmonary arterial venous malformations as primary manifestation of gestational trophoblastic neoplasia
por: Cain, Abigail, et al.
Publicado: (2020)

The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia
por: Liu, Yuanyuan, et al.
Publicado: (2023)

Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
por: Kemin, Li, et al.
Publicado: (2022)

Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Sheikhhasani, Shahrzad, et al.
Publicado: (2023)

Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia
por: Cheng, Hongyan, et al.
Publicado: (2023)

Repeat Curettage In the Management of Low-Risk Gestational Trophoblastic Neoplasia (GTN)
por: Aminimoghaddam, Soheila, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c842esd5k1lpsavdspqu5mds32